{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T01:24:59Z","timestamp":1778117099783,"version":"3.51.4"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bioadv.2025.214343","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T16:01:20Z","timestamp":1747152080000},"page":"214343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Lyophilised reservoirs in combination with hydrogel-forming microarray patches for transdermal delivery of isoniazid and pyridoxine hydrochloride"],"prefix":"10.1016","volume":"176","author":[{"given":"Qonita Kurnia","family":"Anjani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron R.J.","family":"Hutton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akmal Hidayat Bin","family":"Sabri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Febri","family":"Annuryanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen O.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan F.","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioadv.2025.214343_bb0005","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.lpm.2017.01.015","article-title":"Tuberculosis elimination and the challenge of latent tuberculosis","volume":"46","author":"Matteelli","year":"2017","journal-title":"Presse Med."},{"key":"10.1016\/j.bioadv.2025.214343_bb0010","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4037\/ccn2009968","article-title":"Tuberculosis: pathophysiology, clinical features, and diagnosis","volume":"29","author":"Knechel","year":"2009","journal-title":"Crit. Care Nurse"},{"key":"10.1016\/j.bioadv.2025.214343_bb0015","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0140-6736(03)14333-4","article-title":"Tuberculosis","volume":"362","author":"Frieden","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.bioadv.2025.214343_bb0020","series-title":"WHO 2020 Global Tuberculosis Report","author":"WHO","year":"2019"},{"key":"10.1016\/j.bioadv.2025.214343_bb0025","series-title":"Preventing Pellagra During Isoniazid Preventive Treatment","author":"Kapata","year":"2022"},{"key":"10.1016\/j.bioadv.2025.214343_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.idcr.2019.e00550","article-title":"Pellagra in isoniazid preventive and antiretroviral therapy","volume":"17","author":"Kipsang","year":"2019","journal-title":"IDCases"},{"key":"10.1016\/j.bioadv.2025.214343_bb0035","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/phpp.12659","article-title":"Pellagra a review exploring causes and mechanisms, including isoniazid-induced pellagra","volume":"37","author":"Prabhu","year":"2021","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"10.1016\/j.bioadv.2025.214343_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.idcr.2020.e00750","article-title":"Drug-related pellagra in a Ugandan woman on isoniazid preventative therapy","volume":"20","author":"Coates","year":"2020","journal-title":"IDCases"},{"key":"10.1016\/j.bioadv.2025.214343_bb0045","doi-asserted-by":"crossref","first-page":"73","DOI":"10.11604\/pamj.2021.39.73.28072","article-title":"A peculiarly characterised case of isoniazid-induced pellagra- 2 ds and a C: a case report","volume":"39","author":"Kabengele","year":"2021","journal-title":"Pan Afr. Med. J."},{"key":"10.1016\/j.bioadv.2025.214343_bb0050","first-page":"1685","article-title":"Isoniazid toxicity","volume":"168","author":"Badrinath","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.bioadv.2025.214343_bb0055","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0041-3879(80)90038-0","article-title":"Pyridoxine supplementation during isoniazid therapy","volume":"61","author":"Snider","year":"1980","journal-title":"Tubercle"},{"key":"10.1016\/j.bioadv.2025.214343_bb0060","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0041-3879(80)90038-0","article-title":"Pyridoxine supplementation during isoniazid therapy","volume":"61","author":"Snider","year":"1980","journal-title":"Tubercle"},{"key":"10.1016\/j.bioadv.2025.214343_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0157725","article-title":"Hepatotoxicity during treatment for tuberculosis in people living with HIV\/AIDS","volume":"11","author":"Ara\u00fajo-Mariz","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bioadv.2025.214343_bb0070","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1440-1746.2007.05207.x","article-title":"Antituberculosis drug-induced hepatotoxicity: concise up-to-date review","volume":"23","author":"Tostmann","year":"2008","journal-title":"J. Gastroenterol. Hepatol. (Australia)"},{"key":"10.1016\/j.bioadv.2025.214343_bb0075","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1164\/rccm.200510-1666ST","article-title":"An official ATS statement: hepatotoxicity of antituberculosis therapy","volume":"174","author":"Saukkonen","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bioadv.2025.214343_bb0080","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1517\/17425247.2014.875528","article-title":"Skin permeabilization for transdermal drug delivery: recent advances and future prospects","volume":"11","author":"Schoellhammer","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"issue":"4","key":"10.1016\/j.bioadv.2025.214343_bb0085","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3390\/pharmaceutics7040438","article-title":"Transdermal drug delivery: innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum","volume":"7","author":"Alkilani","year":"2015","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioadv.2025.214343_bb0090","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1002\/adfm.201200864","article-title":"Hydrogel-forming microneedle arrays for enhanced transdermal drug delivery","volume":"22","author":"Donnelly","year":"2012","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.bioadv.2025.214343_bb0095","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jconrel.2023.05.038","article-title":"Microarray patches for managing infections at a global scale","volume":"359","author":"Anjani","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214343_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0111547","article-title":"Hydrogel-forming microneedles prepared from \u201csuper swelling\u201d polymers combined with lyophilised wafers for transdermal drug delivery","volume":"9","author":"Donnelly","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bioadv.2025.214343_bb0105","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jconrel.2018.07.009","article-title":"Hydrogel-forming microneedles enhance transdermal delivery of metformin hydrochloride","volume":"285","author":"Migdadi","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214343_bb0110","doi-asserted-by":"crossref","first-page":"121593","DOI":"10.1016\/j.ijpharm.2022.121593","article-title":"Development and characterization of a dry reservoir-hydrogel-forming microneedles composite for minimally invasive delivery of cefazolin","volume":"617","author":"Bin Sabri","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214343_bb0115","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ejpb.2020.12.003","article-title":"Versatility of hydrogel-forming microneedles in in vitro transdermal delivery of tuberculosis drugs","volume":"294\u2013312","author":"Anjani","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bioadv.2025.214343_bb0120","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jconrel.2022.06.028","article-title":"Hydrogel-forming microarray patches with cyclodextrin drug reservoirs for long-acting delivery of poorly soluble cabotegravir sodium for HIV Pre-Exposure Prophylaxis","volume":"348","author":"Volpe-Zanutto","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214343_bb0125","doi-asserted-by":"crossref","first-page":"123081","DOI":"10.1016\/j.ijpharm.2023.123081","article-title":"A five-day treatment course of zanamivir for the flu with a single, self-administered, painless microneedle array patch: revolutionizing delivery of poorly membrane-permeable therapeutics","volume":"641","author":"Reyna","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214343_bb0130","series-title":"Microneedle-mediated transdermal and intradermal drug delivery","author":"Donnelly","year":"2012"},{"key":"10.1016\/j.bioadv.2025.214343_bb0135","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ejpb.2010.03.012","article-title":"Formulation and characterisation of lyophilised rapid disintegrating tablets using amino acids as matrix forming agents","volume":"75","author":"AlHusban","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bioadv.2025.214343_bb0140","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/03639040500528913","article-title":"Formulation of a fast-dissolving ketoprofen tablet using freeze-drying in blisters technique","volume":"32","author":"Ahmed","year":"2006","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.bioadv.2025.214343_bb0145","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0378-5173(97)00092-6","article-title":"Formulation and production of rapidly disintegrating tablets by lyophilisation using hydrochlorothiazide as a model drug","volume":"152","author":"Corveleyn","year":"1997","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214343_bb0150","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ejpb.2020.12.003","article-title":"Versatility of hydrogel-forming microneedles in in vitro transdermal delivery of tuberculosis drugs","volume":"158","author":"Anjani","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bioadv.2025.214343_bb0155","doi-asserted-by":"crossref","first-page":"121049","DOI":"10.1016\/j.ijpharm.2021.121049","article-title":"Synthesis and characterization of sorbitol laced hydrogel-forming microneedles for therapeutic drug monitoring","volume":"607","author":"Hidayat Bin Sabri","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214343_bb0160","article-title":"Development and characterization of a dry reservoir-hydrogel-forming microneedles composite for minimally invasive delivery of cefazolin","volume":"617","author":"Bin Sabri","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214343_bb0165","doi-asserted-by":"crossref","first-page":"121593","DOI":"10.1016\/j.ijpharm.2022.121593","article-title":"Development and characterization of a dry reservoir-hydrogel-forming microneedles composite for minimally invasive delivery of cefazolin","volume":"617","author":"Bin Sabri","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214343_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124071","article-title":"Parafilm\u00ae M and Strat-M\u00ae as skin simulants in in vitro permeation of dissolving microarray patches loaded with proteins","volume":"655","author":"Anjani","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214343_bb0175","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijpharm.2014.05.042","article-title":"A proposed model membrane and test method for microneedle insertion studies","volume":"472","author":"Larraneta","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.bioadv.2025.214343_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/ph15010020","article-title":"Inclusion complexes of Rifampicin with native and derivatized cyclodextrins: in silico modeling, formulation, and characterization","volume":"15","author":"Anjani","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.bioadv.2025.214343_bb0185","doi-asserted-by":"crossref","first-page":"213073","DOI":"10.1016\/j.bioadv.2022.213073","article-title":"Metronidazole nanosuspension loaded dissolving microarray patches: an engineered composite pharmaceutical system for the treatment of skin and soft tissue infection","volume":"140","author":"Anjani","year":"2022","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.bioadv.2025.214343_bb0190","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1039\/C8CS00420J","article-title":"Osmosis, from molecular insights to large-scale applications","volume":"48","author":"Marbach","year":"2019","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioadv.2025.214343_bb0195","doi-asserted-by":"crossref","first-page":"121049","DOI":"10.1016\/j.ijpharm.2021.121049","article-title":"Synthesis and characterization of sorbitol laced hydrogel-forming microneedles for therapeutic drug monitoring","volume":"607","author":"Hidayat Bin Sabri","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214343_bb0200","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1021\/acs.molpharmaceut.1c00988","article-title":"Elucidating the impact of surfactants on the performance of dissolving microneedle array patches","volume":"19","author":"Anjani","year":"2022","journal-title":"Mol. Pharm."},{"issue":"20","key":"10.1016\/j.bioadv.2025.214343_bb0205","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.1039\/D2BM01068B","article-title":"Soluplus\u00ae-based dissolving microarray patches loaded with colchicine: towards a minimally invasive treatment and management of gout","volume":"10","author":"Anjani","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.bioadv.2025.214343_bb0210","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijpharm.2014.05.042","article-title":"A proposed model membrane and test method for microneedle insertion studies","volume":"472","author":"Larra\u00f1eta","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214343_bb0215","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jconrel.2022.06.028","article-title":"Hydrogel-forming microarray patches with cyclodextrin drug reservoirs for long-acting delivery of poorly soluble cabotegravir sodium for HIV pre-exposure prophylaxis","volume":"348","author":"Volpe-Zanutto","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214343_bb0220","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.addr.2019.10.004","article-title":"Intradermal and transdermal drug delivery using microneedles \u2013 fabrication, performance evaluation and application to lymphatic delivery","volume":"153","author":"Sabri","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioadv.2025.214343_bb0225","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.eurpolymj.2008.12.019","article-title":"Investigation of swelling and network parameters of poly(ethylene glycol)-crosslinked poly(methyl vinyl ether-co-maleic acid) hydrogels","volume":"45","author":"Raj Singh","year":"2009","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.bioadv.2025.214343_bb0230","doi-asserted-by":"crossref","first-page":"9487","DOI":"10.1007\/s00253-020-10929-w","article-title":"Sugar alcohols derived from lactose: lactitol, galactitol, and sorbitol","volume":"104","author":"Zhang","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.bioadv.2025.214343_bb0235","article-title":"Metronidazole nanosuspension loaded dissolving microarray patches: an engineered composite pharmaceutical system for the treatment of skin and soft tissue infection","volume":"140","author":"Kurnia","year":"2022","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.bioadv.2025.214343_bb0240","doi-asserted-by":"crossref","first-page":"213073","DOI":"10.1016\/j.bioadv.2022.213073","article-title":"Metronidazole nanosuspension loaded dissolving microarray patches: an engineered composite pharmaceutical system for the treatment of skin and soft tissue infection","volume":"140","author":"Anjani","year":"2022","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.bioadv.2025.214343_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2023.111836","article-title":"Multifunctional low temperature-cured PVA\/PVP\/citric acid-based hydrogel forming microarray patches: physicochemical characteristics and hydrophilic drug interaction","volume":"186","author":"Himawan","year":"2023","journal-title":"Eur. Polym. J."},{"issue":"1","key":"10.1016\/j.bioadv.2025.214343_bb0250","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s13346-023-01393-w","article-title":"Map-box: a novel, low-cost and easy-to-fabricate 3d-printed box for the storage and transportation of dissolving microneedle array patches","volume":"14","author":"Anjani","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.bioadv.2025.214343_bb0255","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3390\/pharmaceutics3030440","article-title":"The influence of formulation and manufacturing process parameters on the characteristics of lyophilized orally disintegrating tablets","volume":"3","author":"Jones","year":"2011","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioadv.2025.214343_bb0260","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3390\/pharmaceutics3030440","article-title":"The influence of formulation and manufacturing process parameters on the characteristics of lyophilized orally disintegrating tablets","volume":"3","author":"Jones","year":"2011","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.bioadv.2025.214343_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-51742-4","article-title":"Improved lyophilization conditions for long-term storage of bacteriophages","volume":"9","author":"Manohar","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioadv.2025.214343_bb0270","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jconrel.2023.02.031","article-title":"Hydrogel-forming microarray patch mediated transdermal delivery of tetracycline hydrochloride","volume":"356","author":"Zhao","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214343_bb0275","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1128\/AAC.43.3.568","article-title":"Pharmacokinetics of ethambutol under fasting conditions, with food, and with antacids","volume":"43","author":"Peloquin","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioadv.2025.214343_bb0280","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/0960327108097431","article-title":"Pharmacokinetic interaction of some antitubercular drugs with caraway: implications in the enhancement of drug bioavailability","volume":"28","author":"Sachin","year":"2009","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.bioadv.2025.214343_bb0285","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.livres.2021.02.001","article-title":"Clinical perspectives of isoniazid-induced liver injury","volume":"5","author":"Lei","year":"2021","journal-title":"Liver Res."},{"key":"10.1016\/j.bioadv.2025.214343_bb0290","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0041-3879(80)90038-0","article-title":"Pyridoxine supplementation during isoniazid therapy","volume":"61","author":"Snider","year":"1980","journal-title":"Tubercle"},{"key":"10.1016\/j.bioadv.2025.214343_bb0295","author":"PubChem. National Library of Medicine (US), National Center for Biotechnology Information"}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950825001700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950825001700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T07:15:04Z","timestamp":1749626104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772950825001700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":59,"alternative-id":["S2772950825001700"],"URL":"https:\/\/doi.org\/10.1016\/j.bioadv.2025.214343","relation":{},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lyophilised reservoirs in combination with hydrogel-forming microarray patches for transdermal delivery of isoniazid and pyridoxine hydrochloride","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioadv.2025.214343","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"214343"}}